Why the study?
Diabetes has been acknowledged as an epidemic with global prevalence growing at approximately 2.5 % per year, prompting an analysis of epidemiological factors for type 2 diabetes mellitus.
Type 2 diabetes continues to show an increasing trend in global burden, reducing life expectancy and highlighting the need for effective health policies.
Observed T2DM burden trends align with GBD expectations across regions; leaves open whether modeled data can reliably guide prevention policies.
BACKGROUND: The United Nations acknowledged diabetes as an epidemic of the 21st century. Global trends demonstrate a continuing growth in its prevalence at approximately 2.5 % per year. The aim of the study was to analyse selected epidemiological factors for type 2 diabetes mellitus in Poland, Central Europe and the World. METHODS: This study presents Global Burden of Disease (GBD) data. Study describes the type 2 diabetes burden in the studied populations based on years lived with disability (YLD), years of life lost (YLL), and disability-adjusted life years (DALYs). RESULTS: Type 2 diabetes has been demonstrated to be a determinant of reduced life expectancy, as in the analysed period the condition presented an increasing trend, compared to other diseases. CONCLUSIONS: In recent years the observed YLL, YLD and DALY values for type 2 diabetes have been comparable to the expected ones. Thus the prognosis presented by GBD may be used as a reliable source of information and a basis for a health policy that reduces the number of patients with diabetes and related complications, comorbidities or mortality.
No takes yet. Share an insight, caveat, or question.
Kotwas et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: